The Effect of Low-Dose Intraoperative Ketamine on Closed-Loop-Controlled General Anesthesia: A Randomized Controlled Equivalence Trial.
Adult
Analgesics, Opioid
/ administration & dosage
Anesthesia, Closed-Circuit
/ adverse effects
Anesthesia, General
/ adverse effects
Anesthetics, Dissociative
/ administration & dosage
Anesthetics, Intravenous
/ administration & dosage
British Columbia
Double-Blind Method
Electroencephalography
Female
Humans
Intraoperative Neurophysiological Monitoring
Ketamine
/ administration & dosage
Male
Middle Aged
Orthopedic Procedures
Postoperative Complications
/ etiology
Propofol
/ administration & dosage
Remifentanil
/ administration & dosage
Time Factors
Treatment Outcome
Young Adult
Journal
Anesthesia and analgesia
ISSN: 1526-7598
Titre abrégé: Anesth Analg
Pays: United States
ID NLM: 1310650
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
pubmed:
10
2
2021
medline:
23
11
2021
entrez:
9
2
2021
Statut:
ppublish
Résumé
Closed-loop control of propofol-remifentanil anesthesia using the processed electroencephalography depth-of-hypnosis index provided by the NeuroSENSE monitor (WAVCNS) has been previously described. The purpose of this placebo-controlled study was to evaluate the performance (percentage time within ±10 units of the setpoint during the maintenance of anesthesia) of a closed-loop propofol-remifentanil controller during induction and maintenance of anesthesia in the presence of a low dose of ketamine. Following ethical approval and informed consent, American Society of Anesthesiologist (ASA) physical status I-II patients aged 19-54 years, scheduled for elective orthopedic surgery requiring general anesthesia for >60 minutes duration, were enrolled in a double-blind randomized, placebo-controlled, 2-group equivalence trial. Immediately before induction of anesthesia, participants in the ketamine group received a 0.25 mg·kg-1 bolus of intravenous ketamine over 60 seconds followed by a continuous 5 µg·kg-1·min-1 infusion for up to 45 minutes. Participants in the control group received an equivalent volume of normal saline. After the initial study drug bolus, closed-loop induction of anesthesia was initiated; propofol and remifentanil remained under closed-loop control until the anesthetic was tapered and turned off at the anesthesiologist's discretion. An equivalence range of ±8.99% was assumed for comparing controller performance. Sixty patients participated: 41 males, 54 ASA physical status I, with a median (interquartile range [IQR]) age of 29 [23, 38] years and weight of 82 [71, 93] kg. Complete data were available from 29 cases in the ketamine group and 27 in the control group. Percentage time within ±10 units of the WAVCNS setpoint was median [IQR] 86.6% [79.7, 90.2] in the ketamine group and 86.4% [76.5, 89.8] in the control group (median difference, 1.0%; 95% confidence interval [CI] -3.6 to 5.0). Mean propofol dose during maintenance of anesthesia for the ketamine group was higher than for the control group (median difference, 24.9 µg·kg-1·min-1; 95% CI, 6.5-43.1; P = .005). Because the 95% CI of the difference in controller performance lies entirely within the a priori equivalence range, we infer that this analgesic dose of ketamine did not alter controller performance. Further study is required to confirm the finding that mean propofol dosing was higher in the ketamine group, and to investigate the implication that this dose of ketamine may have affected the WAVCNS.
Sections du résumé
BACKGROUND
Closed-loop control of propofol-remifentanil anesthesia using the processed electroencephalography depth-of-hypnosis index provided by the NeuroSENSE monitor (WAVCNS) has been previously described. The purpose of this placebo-controlled study was to evaluate the performance (percentage time within ±10 units of the setpoint during the maintenance of anesthesia) of a closed-loop propofol-remifentanil controller during induction and maintenance of anesthesia in the presence of a low dose of ketamine.
METHODS
Following ethical approval and informed consent, American Society of Anesthesiologist (ASA) physical status I-II patients aged 19-54 years, scheduled for elective orthopedic surgery requiring general anesthesia for >60 minutes duration, were enrolled in a double-blind randomized, placebo-controlled, 2-group equivalence trial. Immediately before induction of anesthesia, participants in the ketamine group received a 0.25 mg·kg-1 bolus of intravenous ketamine over 60 seconds followed by a continuous 5 µg·kg-1·min-1 infusion for up to 45 minutes. Participants in the control group received an equivalent volume of normal saline. After the initial study drug bolus, closed-loop induction of anesthesia was initiated; propofol and remifentanil remained under closed-loop control until the anesthetic was tapered and turned off at the anesthesiologist's discretion. An equivalence range of ±8.99% was assumed for comparing controller performance.
RESULTS
Sixty patients participated: 41 males, 54 ASA physical status I, with a median (interquartile range [IQR]) age of 29 [23, 38] years and weight of 82 [71, 93] kg. Complete data were available from 29 cases in the ketamine group and 27 in the control group. Percentage time within ±10 units of the WAVCNS setpoint was median [IQR] 86.6% [79.7, 90.2] in the ketamine group and 86.4% [76.5, 89.8] in the control group (median difference, 1.0%; 95% confidence interval [CI] -3.6 to 5.0). Mean propofol dose during maintenance of anesthesia for the ketamine group was higher than for the control group (median difference, 24.9 µg·kg-1·min-1; 95% CI, 6.5-43.1; P = .005).
CONCLUSIONS
Because the 95% CI of the difference in controller performance lies entirely within the a priori equivalence range, we infer that this analgesic dose of ketamine did not alter controller performance. Further study is required to confirm the finding that mean propofol dosing was higher in the ketamine group, and to investigate the implication that this dose of ketamine may have affected the WAVCNS.
Identifiants
pubmed: 33560659
doi: 10.1213/ANE.0000000000005372
pii: 00000539-202111000-00020
doi:
Substances chimiques
Analgesics, Opioid
0
Anesthetics, Dissociative
0
Anesthetics, Intravenous
0
Ketamine
690G0D6V8H
Remifentanil
P10582JYYK
Propofol
YI7VU623SF
Types de publication
Equivalence Trial
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1215-1224Informations de copyright
Copyright © 2021 International Anesthesia Research Society.
Déclaration de conflit d'intérêts
Conflicts of Interest: See Disclosures at the end of the article.
Références
Dumont GA, Ansermino JM. Closed-loop control of anesthesia: a primer for anesthesiologists. Anesth Analg. 2013;117:1130–1138.
Pasin L, Nardelli P, Pintaudi M, et al. Closed-loop delivery systems versus manually controlled administration of total IV anesthesia: a meta-analysis of randomized clinical trials. Anesth Analg. 2017;124:456–464.
Chan MTV, Hedrick TL, Egan TD, et al.; Perioperative Quality Initiative (POQI) 6 Workgroup. American society for enhanced recovery and perioperative quality initiative joint consensus statement on the role of neuromonitoring in perioperative outcomes: electroencephalography. Anesth Analg. 2020;130:1278–1291.
West N, van Heusden K, Görges M, et al.Design and evaluation of a closed-loop anesthesia system with robust control and safety system. Anesth Analg. 2018;127:883–894.
Brinck EC, Tiippana E, Heesen M, et al. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev. 2018;12:CD012033.
Dal D, Kose A, Honca M, Akinci SB, Basgul E, Aypar U. Efficacy of prophylactic ketamine in preventing postoperative shivering. Br J Anaesth. 2005;95:189–192.
Lee U, Ku S, Noh G, Baek S, Choi B, Mashour GA. Disruption of frontal-parietal communication by ketamine, propofol, and sevoflurane. Anesthesiology. 2013;118:1264–1275.
John ER, Prichep LS. The anesthetic cascade: a theory of how anesthesia suppresses consciousness. Anesthesiology. 2005;102:447–471.
Zikov T, Bibian S, Dumont GA, Huzmezan M, Ries CR. Quantifying cortical activity during general anesthesia using wavelet analysis. IEEE Trans Biomed Eng. 2006;53:617–632.
Hayashi K, Tsuda N, Sawa T, Hagihira S. Ketamine increases the frequency of electroencephalographic bicoherence peak on the alpha spindle area induced with propofol. Br J Anaesth. 2007;99:389–395.
van Heusden K, Cooke E, Brodie S, et al. Effect of ketamine on the NeuroSENSE WAVcns during propofol anesthesia; a randomized feasibility trial. J Clin Monit Comput. Published online April 19, 2020. doi: 10.1007/s10877-020-00511-0
doi: 10.1007/s10877-020-00511-0
Schwenk ES, Viscusi ER, Buvanendran A, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43:456–466.
Brogi E, Cyr S, Kazan R, Giunta F, Hemmerling TM. Clinical performance and safety of closed-loop systems: a systematic review and meta-analysis of randomized controlled trials. Anesth Analg. 2017;124:446–455.
van Heusden K, Ansermino JM, Dumont GA. Robust MISO control of propofol-remifentanil anesthesia guided by the NeuroSENSE monitor. IEEE Trans Control Syst Technol. 2018;26:1758–1770.
Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011;152:2399–2404.
Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91:693–700.
Mehta CR, Patel NR. A network algorithm for performing Fisher’s exact test in r × c contingency tables. J Am Stat Assoc. 1983;78:427–434.
Puri GD, Mathew PJ, Biswas I, et al. A multicenter evaluation of a closed-loop anesthesia delivery system: a randomized controlled trial. Anesth Analg. 2016;122:106–114.
Jones B, Jarvis P, Lewis JA, Ebbutt AF. Trials to assess equivalence: the importance of rigorous methods. BMJ. 1996;313:36–39.
Loeb RG, Cannesson M. Closed-loop anesthesia: ready for prime time? Anesth Analg. 2017;124:381–382.
Bansal VK, Hester DL. Closed-loop anesthesia: not ready for takeoff. Anesth Analg. 2017;125:360–361.
Neckebroek M, Boldingh JHL, De Smet T, Struys MMRF. Influence of remifentanil on the control performance of the bispectral index controlled bayesian-based closed-loop system for propofol administration. Anesth Analg. 2020;130:1661–1669.
Brodie SM, Görges M, Ansermino JM, Dumont GA, Merchant RN. Closed-loop control of total intravenous anesthesia during significant intraoperative blood loss: a case report. A A Case Rep. 2017;9:239–243.
Joosten A, Jame V, Alexander B, et al. Feasibility of fully automated hypnosis, analgesia, and fluid management using 2 independent closed-loop systems during major vascular surgery: a pilot study. Anesth Analg. 2019;128:e88–e92.
Zaouter C, Hemmerling TM, Lanchon R, et al. The feasibility of a completely automated total IV anesthesia drug delivery system for cardiac surgery. Anesth Analg. 2016;123:885–893.
Mahajan V, Samra T, Puri GD; Head of Department of Anesthesia. Anaesthetic depth control using closed loop anaesthesia delivery system vs. target controlled infusion in patients with moderate to severe left ventricular systolic dysfunction. J Clin Anesth. 2017;42:106–113.
Joosten A, Delaporte A, Cannesson M, et al. Fully automated anesthesia and fluid management using multiple physiologic closed-loop systems in a patient undergoing high-risk surgery. A A Case Rep. 2016;7:260–265.
Liu N, Le Guen M, Benabbes-Lambert F, et al. Feasibility of closed-loop titration of propofol and remifentanil guided by the spectral M-Entropy monitor. Anesthesiology. 2012;116:286–295.
Vereecke HE, Vanluchene AL, Mortier EP, Everaert K, Struys MM. The effects of ketamine and rocuronium on the A-Line auditory evoked potential index, Bispectral Index, and spectral entropy monitor during steady state propofol and remifentanil anesthesia. Anesthesiology. 2006;105:1122–1134.
Faraoni D, Salengros JC, Engelman E, Ickx B, Barvais L. Ketamine has no effect on bispectral index during stable propofol-remifentanil anaesthesia. Br J Anaesth. 2009;102:336–339.
Maksimow A, Särkelä M, Långsjö JW, et al. Increase in high frequency EEG activity explains the poor performance of EEG spectral entropy monitor during S-ketamine anesthesia. Clin Neurophysiol. 2006;117:1660–1668.
Petersen CL, Görges M, Massey R, Dumont GA, Ansermino JM. A procedural electroencephalogram simulator for evaluation of anesthesia monitors. Anesth Analg. 2016;123:1136–1140.
Schüler SS, Petersen CL, West NC, Ansermino JM, Merchant RN, Görges M. The effect of ketamine on depth of hypnosis indices during total intravenous anesthesia—a comparative study using a novel electroencephalography case replay system. J Clin Monit Comput. Published online July 25, 2020. doi: 10.1007/s10877-020-00565-0
doi: 10.1007/s10877-020-00565-0
Dutta A, Sethi N, Sood J, et al. The effect of dexmedetomidine on propofol requirements during anesthesia administered by bispectral index-guided closed-loop anesthesia delivery system: a randomized controlled study. Anesth Analg. 2019;129:84–91.
Ma J, Wang XY, Sun QX, et al. Transversus abdominis plane block reduces remifentanil and propofol consumption, evaluated by closed-loop titration guided by bispectral index. Exp Ther Med. 2018;16:3897–3902.
Bataille A, Guirimand A, Szekely B, et al. Does a hypnosis session reduce the required propofol dose during closed-loop anaesthesia induction?: a randomised controlled trial. Eur J Anaesthesiol. 2018;35:675–681.
Bataille A, Besset S, Szekely B, et al. Impact of a preoperative conversational hypnotic session on propofol consumption using closed-loop anesthetic induction guided by the bispectral index: a randomized controlled trial. Medicine (Baltimore). 2017;96:e6389.
Bataille A, Letourneulx JF, Charmeau A, et al. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: a randomised double-blind placebo-controlled study. Eur J Anaesthesiol. 2016;33:898–905.
Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17:131–157.